Investing.com -- China has approved GSK Plc ’s (LON:GSK) Nucala as an add-on maintenance treatment for adults with chronic obstructive pulmonary disease marked by raised blood eosinophils, the company ...

Read More »

Chiny zatwierdzają lek Nucala firmy GSK dla dorosłych z przewlekłą chorobą płuc

Brytyjska firma biofarmaceutyczna poinformowała, że Narodowa Administracja Produktów Medycznych Chin zatwierdziła lek, znany również jako mepolizumab, dla dorosłych, których POChP pozostaje słabo ...

Read More »

GSK agrees to lower drug prices for Americans in deal with US government

Investing.com -- GSK plc (LON:GSK) has entered into an agreement with the U.S. government to reduce prescription medicine costs for American patients, particularly for its respiratory portfolio that ...

Read More »

GSK lifts full-year guidance as Q3 profit more than doubles; shares jump 3%

Investing.com -- GSK Plc (LON:GSK) raised its full-year 2025 guidance after a strong third quarter, sending shares up over 3% on Wednesday as profit and earnings surged on strength in Specialty ...

Read More »

GSK (LON:GSK) Will Pay A Dividend Of £0.16

The board of GSK plc (LON:GSK) has announced that it will pay a dividend on the 10th of July, with investors receiving £0.16 per share. This will take the dividend yield to an attractive 4.2%, ...

Read More »